Company intelligence / Profile preview

Qunlin

Ownership: Private
Development stage: Other

Overview

Qunlin Medical is a Chinese life sciences technology company specializing in lab automation and high-throughput screening solutions. The company develops and manufactures automated liquid handling workstations, high-throughput biological sample processing systems, and integrated laboratory software. Their products are designed to accelerate drug discovery, clinical diagnostics, and genomic research by automating repetitive manual tasks with high precision. Qunlin's technology is widely utilized by pharmaceutical companies, CROs, and academic research institutions to improve experimental efficiency and data reproducibility.

Industry: Drug Discovery Services

Beyond the preview

Go deeper on Qunlin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qunlin.